Article

TearLab acquires AOA’s OcuHub technology platform

TearLab Corp. has closed the acquisition of the assets of the OcuHub business unit from AOAExcel Inc.-the for-profit subsidiary of the American Optometric Association (AOA).

 

San Diego-TearLab Corp. has closed the acquisition of the assets of the OcuHub business unit from AOAExcel Inc.-the for-profit subsidiary of the American Optometric Association (AOA).

As of the close of the transaction, the OcuHub-purchased assets and business activities will be operated out of a fully owned subsidiary of TearLab.

Barry Barresi, OcuHub’s chief executive officer (CEO) and former executive director of the AOA, will remain in his position at TearLab’s OcuHub subsidiary.

The net purchase was about $1.4 million-paid in cash-and the company is in the process of completing the analysis of the accounting treatment of the transaction.

“We believe that the OcuHub offering is completely aligned with our corporate mission to partner with the eye-care community to deliver innovative technologies that enable doctors to provide the highest quality of care for their patients,” said Elias Vamvakas, TearLab’s CEO. “We are excited to welcome Barry and his team to the TearLab family and look forward to updating everyone on OcuHub’s progress as we move forward.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.